Scott Cramer
Concepts (431)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 39 | 2025 | 1031 | 4.100 |
Why?
| | MAP Kinase Kinase Kinases | 8 | 2021 | 73 | 2.390 |
Why?
| | Prostate | 11 | 2014 | 175 | 1.890 |
Why?
| | Receptors, Androgen | 8 | 2021 | 149 | 1.210 |
Why?
| | DNA Helicases | 4 | 2021 | 145 | 1.170 |
Why?
| | Prostate-Specific Antigen | 9 | 2013 | 161 | 1.000 |
Why?
| | Hyperoxaluria, Primary | 5 | 2009 | 14 | 0.930 |
Why?
| | Epithelial Cells | 10 | 2016 | 1093 | 0.890 |
Why?
| | Calcitriol | 6 | 2011 | 58 | 0.880 |
Why?
| | Vitamin D | 4 | 2013 | 395 | 0.880 |
Why?
| | DNA-Binding Proteins | 5 | 2021 | 1500 | 0.820 |
Why?
| | Alcohol Oxidoreductases | 7 | 2011 | 62 | 0.810 |
Why?
| | Interleukin-1alpha | 2 | 2013 | 58 | 0.770 |
Why?
| | Stromal Cells | 2 | 2014 | 111 | 0.650 |
Why?
| | RNA Interference | 2 | 2021 | 464 | 0.640 |
Why?
| | Homologous Recombination | 1 | 2019 | 26 | 0.630 |
Why?
| | Androgens | 4 | 2021 | 187 | 0.580 |
Why?
| | Stem Cells | 3 | 2011 | 590 | 0.530 |
Why?
| | DNA Damage | 1 | 2019 | 418 | 0.520 |
Why?
| | Cell Line, Tumor | 17 | 2021 | 3399 | 0.510 |
Why?
| | Receptors, Calcitriol | 5 | 2015 | 55 | 0.510 |
Why?
| | Cell Division | 9 | 2011 | 796 | 0.490 |
Why?
| | Tumor Suppressor Proteins | 2 | 2012 | 327 | 0.480 |
Why?
| | Epoxy Compounds | 2 | 2015 | 33 | 0.480 |
Why?
| | Genomic Instability | 1 | 2015 | 53 | 0.470 |
Why?
| | Carnitine O-Palmitoyltransferase | 2 | 2015 | 46 | 0.470 |
Why?
| | Autophagy | 5 | 2020 | 281 | 0.460 |
Why?
| | Anticarcinogenic Agents | 2 | 2014 | 77 | 0.450 |
Why?
| | Lactones | 1 | 2014 | 56 | 0.430 |
Why?
| | Breast | 2 | 2014 | 150 | 0.430 |
Why?
| | Genistein | 2 | 2004 | 13 | 0.420 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2014 | 1683 | 0.420 |
Why?
| | Signal Transduction | 7 | 2022 | 5065 | 0.420 |
Why?
| | Enzyme Inhibitors | 3 | 2014 | 838 | 0.400 |
Why?
| | Cell Proliferation | 9 | 2021 | 2473 | 0.400 |
Why?
| | Nuclear Proteins | 2 | 2015 | 710 | 0.390 |
Why?
| | Animals | 35 | 2025 | 36768 | 0.380 |
Why?
| | Cell Cycle | 4 | 2021 | 601 | 0.380 |
Why?
| | Repressor Proteins | 1 | 2015 | 424 | 0.380 |
Why?
| | Male | 52 | 2025 | 67361 | 0.380 |
Why?
| | Mice | 25 | 2022 | 17731 | 0.370 |
Why?
| | Cells, Cultured | 13 | 2015 | 4194 | 0.370 |
Why?
| | Intermediate Filament Proteins | 1 | 2011 | 57 | 0.350 |
Why?
| | Adult Stem Cells | 1 | 2011 | 39 | 0.350 |
Why?
| | Chromones | 1 | 2010 | 44 | 0.350 |
Why?
| | Polymorphism, Single Nucleotide | 8 | 2013 | 2190 | 0.340 |
Why?
| | Mice, Knockout | 8 | 2015 | 2999 | 0.340 |
Why?
| | Neoplastic Stem Cells | 2 | 2011 | 397 | 0.330 |
Why?
| | Necrosis | 4 | 2020 | 244 | 0.330 |
Why?
| | Morpholines | 1 | 2010 | 121 | 0.330 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2011 | 436 | 0.320 |
Why?
| | Nerve Tissue Proteins | 2 | 2011 | 596 | 0.320 |
Why?
| | Gene Deletion | 3 | 2011 | 392 | 0.290 |
Why?
| | Pregnancy, Animal | 3 | 1992 | 52 | 0.290 |
Why?
| | Neoplasm Invasiveness | 4 | 2015 | 507 | 0.280 |
Why?
| | Humans | 60 | 2025 | 136783 | 0.280 |
Why?
| | Cell Differentiation | 4 | 2014 | 1980 | 0.280 |
Why?
| | Carcinoma, Pancreatic Ductal | 1 | 2011 | 285 | 0.280 |
Why?
| | Mutation, Missense | 3 | 2009 | 338 | 0.270 |
Why?
| | Gene Expression Regulation, Neoplastic | 4 | 2021 | 1396 | 0.260 |
Why?
| | Hyperoxaluria | 2 | 2011 | 3 | 0.260 |
Why?
| | Clinical Enzyme Tests | 1 | 2006 | 11 | 0.260 |
Why?
| | Promoter Regions, Genetic | 4 | 2009 | 1250 | 0.250 |
Why?
| | Prostatic Hyperplasia | 2 | 2004 | 42 | 0.250 |
Why?
| | Spectrophotometry | 1 | 2006 | 61 | 0.250 |
Why?
| | Calcifediol | 3 | 2015 | 33 | 0.250 |
Why?
| | Gene Expression Regulation | 6 | 2011 | 2603 | 0.250 |
Why?
| | Cell Lineage | 1 | 2007 | 347 | 0.250 |
Why?
| | PTEN Phosphohydrolase | 5 | 2019 | 162 | 0.240 |
Why?
| | Pancreatic Neoplasms | 2 | 2011 | 931 | 0.230 |
Why?
| | Systems Biology | 1 | 2025 | 66 | 0.230 |
Why?
| | Genotype | 7 | 2008 | 1919 | 0.230 |
Why?
| | Biomarkers, Tumor | 4 | 2019 | 1274 | 0.220 |
Why?
| | Cyclins | 1 | 2004 | 91 | 0.210 |
Why?
| | Allelic Imbalance | 1 | 2003 | 9 | 0.210 |
Why?
| | Endocrinology | 1 | 2004 | 79 | 0.210 |
Why?
| | Fibroblasts | 2 | 2014 | 989 | 0.210 |
Why?
| | Cell Cycle Proteins | 3 | 2010 | 611 | 0.210 |
Why?
| | Proteins | 4 | 1997 | 1009 | 0.210 |
Why?
| | Leukocytes, Mononuclear | 1 | 2006 | 556 | 0.200 |
Why?
| | Specimen Handling | 1 | 2004 | 178 | 0.200 |
Why?
| | Polymorphism, Genetic | 2 | 2003 | 657 | 0.200 |
Why?
| | Tumor Cells, Cultured | 8 | 2015 | 953 | 0.200 |
Why?
| | Receptors, Somatotropin | 2 | 1992 | 9 | 0.200 |
Why?
| | Linkage Disequilibrium | 1 | 2003 | 268 | 0.200 |
Why?
| | Cell Communication | 1 | 2004 | 314 | 0.200 |
Why?
| | Apoptosis | 6 | 2016 | 2548 | 0.200 |
Why?
| | Antineoplastic Agents | 2 | 2004 | 2129 | 0.190 |
Why?
| | Parathyroid Hormone | 3 | 1997 | 108 | 0.180 |
Why?
| | Drug Synergism | 3 | 2010 | 378 | 0.180 |
Why?
| | Phenylthiohydantoin | 1 | 2021 | 42 | 0.180 |
Why?
| | Logistic Models | 2 | 2021 | 2060 | 0.170 |
Why?
| | 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 2 | 2015 | 17 | 0.170 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2021 | 1055 | 0.170 |
Why?
| | Prostatectomy | 2 | 2013 | 104 | 0.170 |
Why?
| | Mutation | 3 | 2007 | 3953 | 0.170 |
Why?
| | Nitriles | 1 | 2021 | 172 | 0.170 |
Why?
| | Pyroptosis | 1 | 2020 | 3 | 0.170 |
Why?
| | Benzamides | 1 | 2021 | 217 | 0.170 |
Why?
| | Neoplasms | 2 | 2014 | 2644 | 0.160 |
Why?
| | Cell Line | 7 | 2012 | 2836 | 0.160 |
Why?
| | Colony-Forming Units Assay | 2 | 2011 | 91 | 0.160 |
Why?
| | Carrier Proteins | 3 | 1992 | 768 | 0.160 |
Why?
| | Immunoblotting | 3 | 2010 | 307 | 0.160 |
Why?
| | Fluorescent Antibody Technique | 2 | 2013 | 386 | 0.150 |
Why?
| | Cellular Senescence | 2 | 2011 | 187 | 0.150 |
Why?
| | Molecular Sequence Data | 6 | 2009 | 2903 | 0.150 |
Why?
| | Polymerase Chain Reaction | 6 | 2009 | 1059 | 0.150 |
Why?
| | ADP-ribosyl Cyclase 1 | 1 | 2018 | 38 | 0.150 |
Why?
| | Point Mutation | 1 | 1999 | 234 | 0.150 |
Why?
| | Osteoblasts | 2 | 1996 | 126 | 0.150 |
Why?
| | Mice, Nude | 3 | 2015 | 692 | 0.140 |
Why?
| | Genetic Markers | 2 | 2013 | 344 | 0.140 |
Why?
| | NAD | 1 | 2018 | 77 | 0.140 |
Why?
| | RNA, Small Interfering | 3 | 2011 | 621 | 0.140 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2021 | 800 | 0.140 |
Why?
| | Meningeal Neoplasms | 1 | 2019 | 100 | 0.140 |
Why?
| | Gene Expression | 5 | 2018 | 1499 | 0.140 |
Why?
| | Regeneration | 2 | 2011 | 194 | 0.140 |
Why?
| | Transfection | 5 | 2018 | 945 | 0.140 |
Why?
| | Flow Cytometry | 4 | 2011 | 1181 | 0.140 |
Why?
| | Membrane Glycoproteins | 2 | 2018 | 500 | 0.130 |
Why?
| | Base Sequence | 6 | 2009 | 2180 | 0.130 |
Why?
| | Neoplasm Grading | 2 | 2015 | 306 | 0.130 |
Why?
| | Cadherins | 2 | 2015 | 205 | 0.120 |
Why?
| | Oxalates | 3 | 2011 | 10 | 0.120 |
Why?
| | Cyclic AMP | 1 | 1996 | 234 | 0.120 |
Why?
| | Transforming Growth Factor beta2 | 2 | 2014 | 36 | 0.120 |
Why?
| | Recombination, Genetic | 2 | 2007 | 198 | 0.120 |
Why?
| | Oncolytic Viruses | 1 | 2015 | 8 | 0.120 |
Why?
| | Oncolytic Virotherapy | 1 | 2015 | 14 | 0.120 |
Why?
| | Vesiculovirus | 1 | 2015 | 16 | 0.120 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2015 | 135 | 0.110 |
Why?
| | Down-Regulation | 2 | 2014 | 657 | 0.110 |
Why?
| | Endotoxins | 1 | 2015 | 220 | 0.110 |
Why?
| | Receptors, Eicosanoid | 2 | 2005 | 2 | 0.110 |
Why?
| | Metabolism | 1 | 2014 | 42 | 0.110 |
Why?
| | Adenocarcinoma | 2 | 2019 | 936 | 0.110 |
Why?
| | Lipid Metabolism | 2 | 2015 | 512 | 0.110 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2005 | 121 | 0.110 |
Why?
| | Oxidation-Reduction | 2 | 2015 | 1062 | 0.110 |
Why?
| | Liver | 3 | 2004 | 1938 | 0.110 |
Why?
| | Random Allocation | 1 | 2014 | 353 | 0.110 |
Why?
| | Proto-Oncogenes | 1 | 2013 | 29 | 0.100 |
Why?
| | Luciferases | 2 | 2003 | 150 | 0.100 |
Why?
| | Litter Size | 1 | 1992 | 17 | 0.100 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 343 | 0.100 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2011 | 765 | 0.100 |
Why?
| | Silymarin | 1 | 2014 | 199 | 0.100 |
Why?
| | DNA Copy Number Variations | 1 | 2013 | 182 | 0.100 |
Why?
| | Hydroxyproline | 1 | 2011 | 21 | 0.090 |
Why?
| | Dietary Fats, Unsaturated | 1 | 2011 | 23 | 0.090 |
Why?
| | Electrophoresis | 1 | 2011 | 32 | 0.090 |
Why?
| | Genes, Retinoblastoma | 1 | 2011 | 8 | 0.090 |
Why?
| | Genes, p16 | 1 | 2011 | 20 | 0.090 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2014 | 864 | 0.090 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2011 | 98 | 0.090 |
Why?
| | Nestin | 1 | 2011 | 19 | 0.090 |
Why?
| | Microfluidic Analytical Techniques | 1 | 2011 | 77 | 0.090 |
Why?
| | Ribonucleosides | 1 | 2010 | 6 | 0.090 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2011 | 103 | 0.090 |
Why?
| | Oxadiazoles | 1 | 2010 | 33 | 0.090 |
Why?
| | Proto-Oncogene Proteins c-pim-1 | 1 | 2010 | 2 | 0.090 |
Why?
| | S-Phase Kinase-Associated Proteins | 1 | 2010 | 20 | 0.090 |
Why?
| | Organ Specificity | 1 | 2011 | 304 | 0.090 |
Why?
| | Cell Separation | 1 | 2011 | 318 | 0.080 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2015 | 856 | 0.080 |
Why?
| | Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2010 | 17 | 0.080 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2011 | 139 | 0.080 |
Why?
| | Disease Progression | 2 | 2015 | 2750 | 0.080 |
Why?
| | Amino Acid Sequence | 3 | 2000 | 2145 | 0.080 |
Why?
| | Hydroxypyruvate Reductase | 2 | 2000 | 2 | 0.080 |
Why?
| | Glucose | 1 | 2015 | 1019 | 0.080 |
Why?
| | Expressed Sequence Tags | 2 | 2000 | 42 | 0.080 |
Why?
| | Endothelial Cells | 1 | 2015 | 778 | 0.080 |
Why?
| | Parathyroid Hormone-Related Protein | 4 | 1997 | 24 | 0.080 |
Why?
| | YY1 Transcription Factor | 1 | 2009 | 25 | 0.080 |
Why?
| | Brain Neoplasms | 1 | 2019 | 1241 | 0.080 |
Why?
| | DNA, Complementary | 2 | 2000 | 269 | 0.080 |
Why?
| | TNF-Related Apoptosis-Inducing Ligand | 3 | 2016 | 51 | 0.080 |
Why?
| | Prostatic Secretory Proteins | 1 | 2009 | 4 | 0.080 |
Why?
| | Physical Chromosome Mapping | 1 | 2009 | 20 | 0.080 |
Why?
| | Chromosomes, Human, Pair 10 | 1 | 2009 | 19 | 0.080 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2000 | 387 | 0.080 |
Why?
| | Genetic Predisposition to Disease | 5 | 2009 | 2417 | 0.080 |
Why?
| | Hypoglycemic Agents | 2 | 2015 | 1281 | 0.070 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2010 | 365 | 0.070 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2010 | 277 | 0.070 |
Why?
| | Risk Factors | 2 | 2021 | 10331 | 0.070 |
Why?
| | Ataxins | 1 | 2007 | 4 | 0.070 |
Why?
| | Ataxin-1 | 1 | 2007 | 4 | 0.070 |
Why?
| | Integrin alpha6 | 1 | 2007 | 9 | 0.070 |
Why?
| | Growth Hormone | 3 | 1992 | 101 | 0.070 |
Why?
| | RNA-Binding Proteins | 3 | 2022 | 424 | 0.070 |
Why?
| | Gene Frequency | 1 | 2009 | 520 | 0.070 |
Why?
| | Rats | 4 | 2015 | 5628 | 0.070 |
Why?
| | Alleles | 2 | 2008 | 888 | 0.070 |
Why?
| | Statistics, Nonparametric | 1 | 2008 | 430 | 0.070 |
Why?
| | Response Elements | 2 | 2009 | 91 | 0.070 |
Why?
| | Cell Movement | 1 | 2012 | 969 | 0.070 |
Why?
| | Chromosomes, Human, Pair 6 | 1 | 2007 | 54 | 0.070 |
Why?
| | Culture Media, Serum-Free | 2 | 2005 | 48 | 0.070 |
Why?
| | Clone Cells | 1 | 2007 | 266 | 0.070 |
Why?
| | Chi-Square Distribution | 1 | 2008 | 532 | 0.070 |
Why?
| | Chromosome Deletion | 1 | 2007 | 115 | 0.070 |
Why?
| | Japan | 1 | 2007 | 116 | 0.070 |
Why?
| | Hydroxyeicosatetraenoic Acids | 2 | 2005 | 43 | 0.070 |
Why?
| | Receptor-Interacting Protein Serine-Threonine Kinases | 2 | 2016 | 14 | 0.070 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 973 | 0.060 |
Why?
| | Middle Aged | 9 | 2013 | 33200 | 0.060 |
Why?
| | Carbohydrate Dehydrogenases | 1 | 2006 | 11 | 0.060 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2007 | 376 | 0.060 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2010 | 2045 | 0.060 |
Why?
| | Blotting, Western | 2 | 2006 | 1225 | 0.060 |
Why?
| | Genetic Vectors | 1 | 2007 | 321 | 0.060 |
Why?
| | RNA, Messenger | 5 | 2011 | 2831 | 0.060 |
Why?
| | Prostatic Diseases | 1 | 2005 | 4 | 0.060 |
Why?
| | DNA, Neoplasm | 2 | 2003 | 164 | 0.060 |
Why?
| | Parainfluenza Virus 5 | 1 | 2005 | 1 | 0.060 |
Why?
| | Viral Structural Proteins | 1 | 2005 | 12 | 0.060 |
Why?
| | Arachidonic Acids | 1 | 2005 | 62 | 0.060 |
Why?
| | Vesicular stomatitis Indiana virus | 1 | 2004 | 13 | 0.060 |
Why?
| | Tolonium Chloride | 1 | 2004 | 3 | 0.060 |
Why?
| | Viral Matrix Proteins | 1 | 2004 | 30 | 0.060 |
Why?
| | ADP Ribose Transferases | 1 | 2004 | 9 | 0.060 |
Why?
| | Glycolates | 1 | 2004 | 4 | 0.060 |
Why?
| | Glyoxylates | 1 | 2004 | 10 | 0.060 |
Why?
| | DNA Mutational Analysis | 2 | 2009 | 400 | 0.060 |
Why?
| | Coloring Agents | 1 | 2004 | 86 | 0.060 |
Why?
| | Calcium Channel Agonists | 1 | 2004 | 12 | 0.060 |
Why?
| | Reference Values | 1 | 2006 | 817 | 0.060 |
Why?
| | Interferon Type I | 1 | 2005 | 141 | 0.050 |
Why?
| | Steroid Hydroxylases | 1 | 2004 | 22 | 0.050 |
Why?
| | Lung | 2 | 2015 | 4065 | 0.050 |
Why?
| | Ergocalciferols | 1 | 2003 | 13 | 0.050 |
Why?
| | Predictive Value of Tests | 2 | 2013 | 2030 | 0.050 |
Why?
| | Adult | 6 | 2013 | 37616 | 0.050 |
Why?
| | Microscopy, Fluorescence | 1 | 2005 | 397 | 0.050 |
Why?
| | Radiation-Sensitizing Agents | 1 | 2003 | 43 | 0.050 |
Why?
| | beta-Galactosidase | 1 | 2003 | 77 | 0.050 |
Why?
| | MicroRNAs | 1 | 2010 | 697 | 0.050 |
Why?
| | Analysis of Variance | 2 | 2003 | 1318 | 0.050 |
Why?
| | Palpation | 1 | 2003 | 15 | 0.050 |
Why?
| | Sequence Analysis, DNA | 2 | 2003 | 811 | 0.050 |
Why?
| | Trinucleotide Repeats | 1 | 2003 | 25 | 0.050 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2004 | 158 | 0.050 |
Why?
| | Gene Amplification | 1 | 2003 | 105 | 0.050 |
Why?
| | Transcription, Genetic | 1 | 2009 | 1453 | 0.050 |
Why?
| | Up-Regulation | 2 | 2004 | 843 | 0.050 |
Why?
| | G2 Phase | 1 | 2002 | 38 | 0.050 |
Why?
| | Phosphoproteins | 1 | 2005 | 338 | 0.050 |
Why?
| | Cell Culture Techniques | 1 | 2005 | 363 | 0.050 |
Why?
| | G1 Phase | 1 | 2002 | 71 | 0.050 |
Why?
| | Reproducibility of Results | 2 | 2011 | 3272 | 0.050 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2002 | 75 | 0.050 |
Why?
| | Viral Proteins | 1 | 2005 | 343 | 0.050 |
Why?
| | Radioimmunoassay | 2 | 1992 | 173 | 0.050 |
Why?
| | Peptide Elongation Factors | 1 | 2022 | 15 | 0.050 |
Why?
| | Cloning, Molecular | 1 | 2003 | 534 | 0.050 |
Why?
| | Genes, Tumor Suppressor | 1 | 2002 | 86 | 0.050 |
Why?
| | Transforming Growth Factor beta | 1 | 2005 | 480 | 0.050 |
Why?
| | Transcription Factors | 1 | 2010 | 1714 | 0.050 |
Why?
| | Embryo, Mammalian | 1 | 2002 | 231 | 0.050 |
Why?
| | Haplotypes | 1 | 2003 | 490 | 0.050 |
Why?
| | In Vitro Techniques | 1 | 2003 | 1089 | 0.040 |
Why?
| | Vitamin D3 24-Hydroxylase | 2 | 2015 | 15 | 0.040 |
Why?
| | Founder Effect | 1 | 2000 | 11 | 0.040 |
Why?
| | Kinetics | 2 | 1996 | 1668 | 0.040 |
Why?
| | Aged | 6 | 2013 | 23729 | 0.040 |
Why?
| | MAP Kinase Signaling System | 1 | 2002 | 321 | 0.040 |
Why?
| | Multienzyme Complexes | 1 | 2000 | 68 | 0.040 |
Why?
| | Codon, Nonsense | 1 | 2000 | 44 | 0.040 |
Why?
| | Glyceric Acids | 1 | 2000 | 6 | 0.040 |
Why?
| | Chromosomes, Human, Pair 9 | 1 | 2000 | 42 | 0.040 |
Why?
| | Mixed Function Oxygenases | 1 | 2000 | 44 | 0.040 |
Why?
| | Polymorphism, Single-Stranded Conformational | 1 | 1999 | 26 | 0.040 |
Why?
| | Consensus Sequence | 1 | 1999 | 73 | 0.040 |
Why?
| | Chemoprevention | 1 | 2000 | 92 | 0.040 |
Why?
| | Gene Knockdown Techniques | 2 | 2011 | 326 | 0.040 |
Why?
| | Microsatellite Repeats | 1 | 2000 | 167 | 0.040 |
Why?
| | Trans-Activators | 1 | 2022 | 397 | 0.040 |
Why?
| | Codon | 1 | 1999 | 89 | 0.040 |
Why?
| | COS Cells | 1 | 1999 | 188 | 0.040 |
Why?
| | Genes | 1 | 1999 | 230 | 0.040 |
Why?
| | Parenchymal Tissue | 1 | 2019 | 6 | 0.040 |
Why?
| | Tissue Distribution | 1 | 2000 | 329 | 0.040 |
Why?
| | Time Factors | 4 | 2009 | 6792 | 0.040 |
Why?
| | Green Fluorescent Proteins | 2 | 2015 | 389 | 0.040 |
Why?
| | Cell Death | 2 | 2015 | 370 | 0.040 |
Why?
| | Transcriptional Regulator ERG | 1 | 2019 | 18 | 0.040 |
Why?
| | Sequence Alignment | 1 | 1999 | 345 | 0.040 |
Why?
| | Sweden | 2 | 2009 | 101 | 0.040 |
Why?
| | Nicotinamide Phosphoribosyltransferase | 1 | 2018 | 7 | 0.040 |
Why?
| | Transaminases | 2 | 2011 | 24 | 0.040 |
Why?
| | Phenotype | 1 | 2007 | 3199 | 0.040 |
Why?
| | Exons | 1 | 1999 | 349 | 0.040 |
Why?
| | Species Specificity | 1 | 1999 | 584 | 0.040 |
Why?
| | Serine Endopeptidases | 1 | 2019 | 123 | 0.040 |
Why?
| | Acrylamides | 1 | 2018 | 57 | 0.040 |
Why?
| | Cellular Reprogramming | 1 | 2018 | 98 | 0.030 |
Why?
| | Tretinoin | 1 | 2018 | 123 | 0.030 |
Why?
| | Recombinant Proteins | 2 | 2015 | 1354 | 0.030 |
Why?
| | Piperidines | 1 | 2018 | 205 | 0.030 |
Why?
| | Receptors, Death Domain | 1 | 2016 | 3 | 0.030 |
Why?
| | Autophagy-Related Protein 5 | 1 | 2016 | 8 | 0.030 |
Why?
| | Autophagosomes | 1 | 2016 | 19 | 0.030 |
Why?
| | Prevalence | 1 | 2003 | 2712 | 0.030 |
Why?
| | Mitochondria | 2 | 2018 | 946 | 0.030 |
Why?
| | Protein Kinases | 1 | 2018 | 319 | 0.030 |
Why?
| | Biomarkers | 1 | 2007 | 4158 | 0.030 |
Why?
| | Culture Media | 1 | 1996 | 167 | 0.030 |
Why?
| | Epidermal Growth Factor | 1 | 1996 | 174 | 0.030 |
Why?
| | Cell Survival | 2 | 2011 | 1117 | 0.030 |
Why?
| | Pregnancy | 3 | 1992 | 6731 | 0.030 |
Why?
| | Epithelium | 1 | 1996 | 311 | 0.030 |
Why?
| | Fatty Acids | 1 | 2018 | 444 | 0.030 |
Why?
| | Genes, Viral | 1 | 2015 | 88 | 0.030 |
Why?
| | Heterografts | 1 | 2015 | 138 | 0.030 |
Why?
| | STAT1 Transcription Factor | 1 | 2015 | 73 | 0.030 |
Why?
| | Poly(ADP-ribose) Polymerases | 2 | 2005 | 99 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2005 | 4279 | 0.030 |
Why?
| | Pertussis Toxin | 2 | 2005 | 26 | 0.030 |
Why?
| | Caspases | 2 | 2005 | 247 | 0.030 |
Why?
| | Lipids | 1 | 2018 | 665 | 0.030 |
Why?
| | Positron-Emission Tomography | 1 | 2015 | 295 | 0.030 |
Why?
| | Case-Control Studies | 3 | 2009 | 3537 | 0.030 |
Why?
| | Female | 5 | 2006 | 72840 | 0.030 |
Why?
| | Placental Lactogen | 1 | 1992 | 23 | 0.020 |
Why?
| | Sheep | 1 | 2015 | 855 | 0.020 |
Why?
| | Phosphorylation | 2 | 2010 | 1756 | 0.020 |
Why?
| | Blotting, Northern | 1 | 1992 | 199 | 0.020 |
Why?
| | Microsomes, Liver | 1 | 1992 | 86 | 0.020 |
Why?
| | Models, Biological | 1 | 2000 | 1769 | 0.020 |
Why?
| | Nephrocalcinosis | 1 | 2011 | 13 | 0.020 |
Why?
| | Transcriptome | 1 | 2018 | 971 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 1996 | 1731 | 0.020 |
Why?
| | Binding, Competitive | 1 | 1992 | 202 | 0.020 |
Why?
| | Protein Binding | 2 | 2010 | 2223 | 0.020 |
Why?
| | Animal Feed | 1 | 2011 | 53 | 0.020 |
Why?
| | Orchiectomy | 1 | 2011 | 71 | 0.020 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2011 | 47 | 0.020 |
Why?
| | Fatty Acid Desaturases | 1 | 2011 | 32 | 0.020 |
Why?
| | Transplantation, Heterologous | 1 | 2011 | 195 | 0.020 |
Why?
| | Gene Knockout Techniques | 1 | 2011 | 115 | 0.020 |
Why?
| | Homozygote | 1 | 2011 | 203 | 0.020 |
Why?
| | Neoplasm Transplantation | 1 | 2011 | 256 | 0.020 |
Why?
| | Sensitivity and Specificity | 2 | 2009 | 1942 | 0.020 |
Why?
| | Proteolysis | 1 | 2011 | 178 | 0.020 |
Why?
| | Spheroids, Cellular | 1 | 2011 | 76 | 0.020 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2011 | 155 | 0.020 |
Why?
| | Peptide Fragments | 1 | 1995 | 707 | 0.020 |
Why?
| | Apc3 Subunit, Anaphase-Promoting Complex-Cyclosome | 1 | 2010 | 1 | 0.020 |
Why?
| | Rabbits | 1 | 1992 | 789 | 0.020 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2015 | 382 | 0.020 |
Why?
| | S Phase | 1 | 2010 | 77 | 0.020 |
Why?
| | Odds Ratio | 1 | 2013 | 1063 | 0.020 |
Why?
| | Ubiquitination | 1 | 2010 | 102 | 0.020 |
Why?
| | Cytokines | 1 | 2018 | 2088 | 0.020 |
Why?
| | Antioxidants | 1 | 2014 | 578 | 0.020 |
Why?
| | Enhancer of Zeste Homolog 2 Protein | 1 | 2010 | 51 | 0.020 |
Why?
| | Neovascularization, Pathologic | 1 | 2011 | 301 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2010 | 345 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2015 | 2481 | 0.020 |
Why?
| | Pulmonary Artery | 1 | 2015 | 1082 | 0.020 |
Why?
| | Polycomb Repressive Complex 2 | 1 | 2010 | 66 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2013 | 1373 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2011 | 728 | 0.020 |
Why?
| | HeLa Cells | 1 | 2010 | 636 | 0.020 |
Why?
| | Antigens, CD | 1 | 2010 | 522 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2009 | 813 | 0.020 |
Why?
| | Computer Simulation | 1 | 2011 | 973 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2011 | 2162 | 0.020 |
Why?
| | Placenta | 1 | 1992 | 747 | 0.020 |
Why?
| | Peroxisome Proliferator-Activated Receptors | 1 | 2005 | 17 | 0.020 |
Why?
| | Prostaglandin D2 | 1 | 2005 | 23 | 0.020 |
Why?
| | Fas-Associated Death Domain Protein | 1 | 2005 | 9 | 0.010 |
Why?
| | Multivariate Analysis | 1 | 2009 | 1513 | 0.010 |
Why?
| | Anilides | 1 | 2005 | 73 | 0.010 |
Why?
| | Poly (ADP-Ribose) Polymerase-1 | 1 | 2005 | 51 | 0.010 |
Why?
| | ADP-Ribosylation Factors | 1 | 2005 | 18 | 0.010 |
Why?
| | Caspase 8 | 1 | 2005 | 48 | 0.010 |
Why?
| | DNA Fragmentation | 1 | 2004 | 41 | 0.010 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2005 | 69 | 0.010 |
Why?
| | Retinoblastoma Protein | 1 | 2005 | 57 | 0.010 |
Why?
| | Peroxisomes | 1 | 2004 | 12 | 0.010 |
Why?
| | Caspase 3 | 1 | 2005 | 246 | 0.010 |
Why?
| | Prognosis | 1 | 2013 | 4018 | 0.010 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2004 | 121 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 2005 | 432 | 0.010 |
Why?
| | PPAR gamma | 1 | 2005 | 182 | 0.010 |
Why?
| | Mitosis | 1 | 2005 | 193 | 0.010 |
Why?
| | Adenoviridae | 1 | 2005 | 193 | 0.010 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2005 | 188 | 0.010 |
Why?
| | Diet | 1 | 2011 | 1273 | 0.010 |
Why?
| | Models, Molecular | 1 | 2009 | 1591 | 0.010 |
Why?
| | Radiation, Ionizing | 1 | 2003 | 81 | 0.010 |
Why?
| | Stimulation, Chemical | 1 | 2002 | 59 | 0.010 |
Why?
| | DNA Primers | 1 | 2004 | 513 | 0.010 |
Why?
| | Carcinoma | 1 | 2005 | 236 | 0.010 |
Why?
| | Phagocytosis | 1 | 2005 | 379 | 0.010 |
Why?
| | Benzoquinones | 1 | 2002 | 48 | 0.010 |
Why?
| | Protein Structure, Tertiary | 1 | 2005 | 867 | 0.010 |
Why?
| | Cattle | 1 | 2005 | 981 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2002 | 152 | 0.010 |
Why?
| | GTP-Binding Proteins | 1 | 2002 | 161 | 0.010 |
Why?
| | Binding Sites | 1 | 2005 | 1308 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2002 | 185 | 0.010 |
Why?
| | Mice, Inbred BALB C | 1 | 2004 | 1267 | 0.010 |
Why?
| | Virus Replication | 1 | 2004 | 479 | 0.010 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2005 | 429 | 0.010 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2005 | 455 | 0.010 |
Why?
| | Probability | 1 | 2002 | 309 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2002 | 313 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2019 | 15564 | 0.010 |
Why?
| | Registries | 1 | 2009 | 2015 | 0.010 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2005 | 530 | 0.010 |
Why?
| | Inflammation | 1 | 2011 | 2834 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2005 | 1242 | 0.010 |
Why?
| | Indoles | 1 | 2002 | 410 | 0.010 |
Why?
| | Genetic Variation | 1 | 2004 | 985 | 0.010 |
Why?
| | Proto-Oncogene Proteins | 1 | 2002 | 646 | 0.010 |
Why?
| | Cell Count | 1 | 1997 | 321 | 0.010 |
Why?
| | Phorbol Esters | 1 | 1995 | 14 | 0.010 |
Why?
| | Teriparatide | 1 | 1995 | 7 | 0.010 |
Why?
| | Colforsin | 1 | 1995 | 53 | 0.010 |
Why?
| | Second Messenger Systems | 1 | 1995 | 31 | 0.010 |
Why?
| | Osteosarcoma | 1 | 1995 | 75 | 0.010 |
Why?
| | Brain | 1 | 2004 | 2669 | 0.010 |
Why?
| | Cohort Studies | 1 | 2002 | 5718 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2002 | 7569 | 0.010 |
Why?
| | Prospective Studies | 1 | 2002 | 7583 | 0.010 |
Why?
|
|
Cramer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|